Draft:Lajos Balogh (scientist)

Lajos Balogh
Born (1950-01-15) January 15, 1950 (age 74)
Komádi, Hajdú-Bihar, Hungary
CitizenshipHungarian-American
EducationPh.D., Kossuth Lajos University
OccupationScientist
Known forPolymer chemistry, dendrimers, and nanomedicine
Websiteprecisionnanomedicine.com

Lajos Peter Balogh (born January 15, 1950), mainly referred to as Lou Balogh, is a Hungarian-American scientist known for his research on polymers, dendrimer nanocomposites, and nanomedicine. Balogh is the editor-in-chief of Precision Nanomedicine (PRNANO). He is also on the World’s Top 2% Scientists list based on career-long citation numbers.[1][2]

Early life and education

edit

Balogh was born on January 15, 1950, in Komádi, Hajdú-Bihar County, Hungary. He studied chemistry at the Debreceni Vegyipari Technikum and the Kossuth Lajos University from 1969 to 1974, earning his Ph.D. in 1983. In 1991, Balogh received an invitation from the University of Massachusetts Lowell and moved to the United States.

Career

edit

Balogh joined UMass Lowell as a visiting professor in 1991. In 1996, he left for the Michigan Molecular Institute to research dendrimers, where he was a senior associate scientist. From 1998 to 2018, Balogh worked as a professor for several universities, including the University of Michigan Ann Arbor, the University at Buffalo, and the Roswell Park Center Institute. He also taught as a visiting professor at the Chinese Academy of Sciences, the Seoul National University, and the Semmelweis University.[3]

Balogh is a board member of several organizations, including the U.S. Technical Advisory Group to ISO on Nanotechnology since 2005 and co-founder of the American Society for Nanomedicine (2008). Since 2011, he has been a board member of the Scientific Committee of the CLINAM Summits and numerous International Steering Committees.[4]

Between 2008 and 2016, Balogh, as editor-in-chief, took an upstart scientific journal (Nanomedicine: Nanotechnology, Biology, and Medicine, Elsevier) from 5 editors and no journal impact factor to 20 editors and JIF2014 =6.9, (5-year JIF=7.5). He increased the journal's readership to over 480,000 downloads per year. In 2017, Balogh initiated Manuscript Clinic, a platform that helped scientists and students publish their research results in nanomedicine and nanotechnology and promoted both nanoscience and scientific writing. In 2018, he founded Andover House, Inc., a not-for-profit online publishing company, and launched Precision Nanomedicine (PRNANO). He serves as the editor-in-chief of this scientists-owned, fully open-access professional journal. PRNANO has been designated the official journal of the International Society for Nanomedicine and CLINAM, the European Society for Clinical Nanomedicine (Basel, Switzerland).[5]

Personal

edit

Balogh is married to Éva Kovács Balogh, a Hungarian American linguist with two children. Peter Balogh was the crew chief of the University of Michigan Solar car team's Momentum, which won first place at the North American Solar Challenge in 2005. Aki Balogh is the President of Marketmuse and a co-founder of DLC.link.

Research work

edit

Balogh is considered an international expert in Nanomedicine and scholarly publications. He published 228 scientific papers, gave over 230 invited lectures, and was awarded 12 patents in chemistry, physics, nanotechnology, and nanomedicine. His publications have been cited over 9500 times (22 papers with more than 100 citations, 11 with more than 200 citations, and 2 cited over 1000 times; h-index=42). Balogh has been listed as belonging to the World's top 2% of Scientists.[6]

Achievements

edit

Balogh is one of the five founders of the American Society for Nanomedicine. He serves on the U.S. Technical Advisory Group to ISO TC 229 Nanotechnology and on the Board of several international and U.S. national organizations. Some recent awards include a visiting professorship for Senior International Scientists at the Chinese Academy of Sciences, Beijing, a KOFST Fellowship at Seoul National University, Seoul, Korea, and a Fulbright Teaching Scholarship at Semmelweis University. Balogh is also on the World’s Top 2% Scientists list based on career-long citation numbers.

Selected publications

edit

Peer-reviewed publications

edit
  • Wolfgang Parak, Beatriz Pelaz, Christoph Alexiou, Ramon A. Alvarez-Puebla, Frauke Alves, Anne M. Andrews, Sumaira Ashraf, Lajos P. Balogh, et al., Diverse Applications of Nanomedicine, ACS Nano. ACS Nano, 2017, 11 (3), pp 2313–2381, DOI: 10.1021/acsnano.6b0604
  • Kukowska-Latallo, Jolanta F. Kimberly A.  Candido, Zhengyi Cao, Shraddha S.  Nigavekar, Istvan J Majoros, Thommey P. Thomas, Lajos P. Balogh, Mohamed K. Khan and James R. Baker, Jr., Nanoparticle Targeting of Anticancer Drug Improves Therapeutic Response in Animal Model of Human Epithelial Cancer, Cancer Research 2005, 65, 5317-5324
  • L. Balogh and Donald A. Tomalia: Poly(Amidoamine) Dendrimer-Templated Nanocomposites I. Synthesis of Zero-Valent Copper Nanoclusters; Journal of Am. Chem. Soc., 1998, 120, 7355-7356
  • Yuliang Zhao, Lajos Balogh, Caging Cancer, Nanomedicine: Nanotechnology, Biology, and Medicine, 11 (2015) 867–869
  • Hong, S. A. U. Bielinska, A. Mecke, B. Keszler, J. L. Beals, X. Shi, L. Balogh, B. G. Orr, J. R. Baker Jr., and M. M. Banaszak Holl, Interaction of Poly(amidoamine) Dendrimers with Supported Lipid Bilayers and Cells: Hole Formation and the Relation to Transport, Bioconj. Chem. 2004, 15, 774-782
  • L Balogh, DR Swanson, DA Tomalia, GL Hagnauer, AT McManus, Dendrimer−silver complexes and nanocomposites as antimicrobial agents, Nano letters 1 (1), 18-21

Books

edit
  • Lajos P. Balogh (Ed), Nanomedicine's Most Cited Series, Vol.2, Nano-Enabled Medical Applications (Taylor & Francis, 2020)
  • Lajos P. Balogh (Ed), Nanomedicine's Most Cited Series, Vol.1, Nanomedicine in Cancer (Taylor & Francis, 2017)

Book chapters

edit
  • Lajos P. Balogh, "Introduction to Nanomedicine" Chapter 1 in Nanomedicine in Health And Disease, Ed: Victor R. Preedy, Science Publishers, 2011, p.3.
  • Lajos P. Balogh, Donald A. Mager and Mohamed K. Khan, “Synthesis and Biodisposition of Dendrimer Composite Nanoparticles,” Chapter 6 in: Materials for Nanomedicine, Eds: V. Torchilin and M. Amiji, World Scientific Publishing, 2010
  • Lajos P. Balogh, Teyeb Ould Ely, and Wojciech G. Lesniak "Composite Nanoparticles for Cancer Imaging and Therapy: Engineering Surface, Composition, and Shape," Chapter 4 in Nanomedicine Design of Particles, Sensors, Motors, Implants, Robots, and Devices, Eds: M. Schulz, V.N. Shanov, ISBN 978-1-59693-279-1, Artech House 2009
  • Lajos P. Balogh, "Dendrimer 101" Chapter 11 (p 136-155) in: "Biological and Biomedical Applications of Engineered Nanostructures" Ed: Warren P. Chan – U. Toronto, Eurekah, 2007.
  • Lajos P Balogh and Mohamed K Khan: Dendrimer Nanocomposites for Cancer Therapy" Chapter 28 (p. 551–592, in Nanotechnology in Cancer Therapy (Ed: Mansour Amiji), CRC Press (Taylor and Francis Group), Boca Raton, London, New York, 2006

Selected patents

edit
  • J. Y. Ye, T. B. Norris, L. P. Balogh, J. R. Baker, Jr., Laser-based Method and System for Enhancing Optical Breakdown, US 7,474,919 B2, January 6, 2009
  • D. A. Tomalia and L. Balogh: "Nanocomposites of Dendritic Polymers" US 6,664,315 B2, December 16, 2003
  • D. A. Tomalia and L. Balogh: "Method and Articles for Transfection of Genetic Material," US 6,475,994, November 5, 2002,
  • L. Balogh, D. R. Swanson, D. A. Tomalia, G. L. Hagnauer, A. T. McManus: "Antimicrobial Dendrimer Nanocomposites and a Method of Treating Wounds," US 6,224,898 B1, May 1, 2001.
  • R. Faust and L. Balogh: U.S. 5,665,837 (1997); Initiation via Haloboration in Living Cationic Polymerization

References

edit
  1. ^ Tse, Christine; Zohdy, Marwa J.; Ye, Jing Yong; O'Donnell, Matthew; Lesniak, Wojciech; Balogh, Lajos (2011-02-01). "Enhanced optical breakdown in KB cells labeled with folate-targeted silver-dendrimer composite nanodevices". Nanomedicine: Nanotechnology, Biology and Medicine. 7 (1): 97–106. doi:10.1016/j.nano.2010.09.003. ISSN 1549-9634. PMC 3026873. PMID 20883823.
  2. ^ Balogh, Lajos; Tomalia, Donald A. (1998). "Poly(Amidoamine) Dendrimer-Templated Nanocomposites. 1. Synthesis of Zerovalent Copper Nanoclusters". Journal of the American Chemical Society. 120 (29): 7355–7356. doi:10.1021/ja980861w. ISSN 0002-7863.
  3. ^ Macdonald, Steph (2019-05-10). "Weekly digest: what's happening in open science?". Open Pharma - Innovations in medical publishing. Retrieved 2024-08-12.
  4. ^ Seo, Young-Soo; Kim, Kwang-Sok; Shin, Kwanwoo; White, Henry; Rafailovich, Miriam; Sokolov, Jonathan; Lin, Binhua; Kim, Hyung Jung; Zhang, Chunxin; Balogh, Lajos (2002-07-01). "Morphology of Amphiphilic Gold/Dendrimer Nanocomposite Monolayers". Langmuir. 18 (15): 5927–5932. doi:10.1021/la025504k. ISSN 0743-7463.
  5. ^ Pelaz, Beatriz; Alexiou, Christoph; Alvarez-Puebla, Ramon A.; Alves, Frauke; Andrews, Anne M.; Ashraf, Sumaira; Balogh, Lajos P.; Ballerini, Laura; Bestetti, Alessandra; Brendel, Cornelia; Bosi, Susanna; Carril, Monica; Chan, Warren C. W.; Chen, Chunying; Chen, Xiaodong (2017). "Diverse Applications of Nanomedicine". ACS Nano. 11 (3): 2313–2381. doi:10.1021/acsnano.6b06040. ISSN 1936-0851. PMC 5371978. PMID 28290206.
  6. ^ Siccardi, Marco; Löffler, Beat; Balogh, Lajos; Owen, Andrew (2017-01-01). "Integrated pharmacokinetic modelling for accelerated nanomedicine translation". European Journal of Nanomedicine. 9 (1): 1–3. doi:10.1515/ejnm-2016-0041. ISSN 1662-596X.